XML 93 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement Of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Other Paid-In Capital
Retained Earnings
Deferred Retirement Benefit Costs
Accumulated Other Comprehensive Income (Loss)
Total Ameren Corporation Stockholders' Equity
Noncontrolling Interest
Ameren Missouri
Ameren Missouri
Common Stock
Ameren Missouri
Other Paid-In Capital
Ameren Missouri
Preferred Stock Not Subject To Mandatory Redemption
Ameren Missouri
Retained Earnings
Ameren Illinois
Ameren Illinois
Common Stock
Ameren Illinois
Other Paid-In Capital
Ameren Illinois
Preferred Stock Not Subject To Mandatory Redemption
Ameren Illinois
Retained Earnings
Common Stock at Dec. 31, 2020     $ 6,179 $ 2,757 $ (1)     $ 142     $ 2,518   $ 2,101     $ 2,652 $ 62 $ 2,252
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Settlement of non-ATM program forward sale agreement through common shares issuance     113                              
Stock Issued During Period, Value, New Issues     148                              
Shares issued under the DRPlus and 401(k) plan     47                              
Stock-based compensation activity     15                              
Capital contribution from parent                 $ 207   207     $ 262   262    
Net income $ 995               521       521 427       427
Net Income (Loss) Available to Common Stockholders, Basic 990     990                            
Common stock dividends       (565)                 (24)         0
Preferred stock dividends                         (3)         (2)
Change in deferred retirement benefit costs 14       14                          
Net income attributable to noncontrolling interest holders $ (5)             5                    
Dividends paid to noncontrolling interest holders               (5)                    
Redemptions of preferred stock               (13)                 (13)  
Beginning of year (shares) at Dec. 31, 2020 253,300,000                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under non-ATM program forward sale agreement 1,600,000                                  
Stock Issued During Period, Shares, New Issues 1,800,000                                  
Shares issued under the DRPlus and 401(k) plan 500,000                                  
Shares issued (in shares) 500,000                                  
End of year (shares) at Dec. 31, 2021 257,700,000                                  
End of year at Dec. 31, 2021 $ 9,829 $ 3 6,502 3,182 13 $ 13   129   $ 511 2,725 $ 80 2,595   $ 0 2,914 49 2,677
Stockholders' equity, end of year at Dec. 31, 2021             $ 9,700   5,911         5,640        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common Stock, Dividends, Per Share, Cash Paid $ 2.20                                  
Settlement of non-ATM program forward sale agreement through common shares issuance     0                              
Stock Issued During Period, Value, New Issues     292                              
Shares issued under the DRPlus and 401(k) plan     49                              
Stock-based compensation activity     17                              
Capital contribution from parent                 0   0     15   15    
Net income $ 1,079               $ 565       565 $ 515       515
Net Income (Loss) Available to Common Stockholders, Basic 1,074     1,074                            
Common stock dividends       (610)                 (46)         0
Preferred stock dividends                         (3)         (2)
Change in deferred retirement benefit costs (14)       (14)                          
Net income attributable to noncontrolling interest holders $ (5)             5                    
Dividends paid to noncontrolling interest holders               (5)                    
Redemptions of preferred stock               0                 0  
Shares issued under non-ATM program forward sale agreement 0                                  
Stock Issued During Period, Shares, New Issues 3,400,000                                  
Shares issued under the DRPlus and 401(k) plan 500,000                                  
Shares issued (in shares) 400,000                                  
End of year (shares) at Dec. 31, 2022 262,000,000.0               102,100,000         25,500,000        
End of year at Dec. 31, 2022 $ 10,637 3 6,860 3,646 (1) (1)   129   511 2,725 80 3,111   0 2,929 49 3,190
Stockholders' equity, end of year at Dec. 31, 2022 $ 10,508           10,508   $ 6,427         $ 6,168        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common Stock, Dividends, Per Share, Cash Paid $ 2.36                                  
Settlement of non-ATM program forward sale agreement through common shares issuance     0                              
Stock Issued During Period, Value, New Issues     299                              
Shares issued under the DRPlus and 401(k) plan     46                              
Stock-based compensation activity     11                              
Capital contribution from parent                 0   0     91   91    
Net income $ 1,157               $ 548       548 $ 609       609
Net Income (Loss) Available to Common Stockholders, Basic 1,152     1,152                            
Common stock dividends       (662)                 (9)         (41)
Preferred stock dividends                         (3)         (2)
Change in deferred retirement benefit costs (5)       (5)                          
Net income attributable to noncontrolling interest holders $ (5)             5                    
Dividends paid to noncontrolling interest holders               (5)                    
Redemptions of preferred stock               0                 0  
Shares issued under non-ATM program forward sale agreement 0                                  
Stock Issued During Period, Shares, New Issues 3,200,000                                  
Shares issued under the DRPlus and 401(k) plan 600,000                                  
Shares issued (in shares) 500,000                                  
End of year (shares) at Dec. 31, 2023 266,300,000               102,100,000         25,500,000        
End of year at Dec. 31, 2023 $ 11,478 $ 3 $ 7,216 $ 4,136 $ (6) $ (6)   $ 129   $ 511 $ 2,725 $ 80 $ 3,647   $ 0 $ 3,020 $ 49 $ 3,756
Stockholders' equity, end of year at Dec. 31, 2023 $ 11,349           $ 11,349   $ 6,963         $ 6,825        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common Stock, Dividends, Per Share, Cash Paid $ 2.52